"Now that we know so much more about tumors and the immune system, we can start utilizing our immune system in the context of gene therapy technology. That means the cell therapies we currently have are a proven principle."
While amyloidosis is not cancer, it is sometimes treated with standards of “cancer-combat” care, and people with multiple myeloma – a blood cancer that begins in the bone marrow – may be at a higher risk for developing amyloidosis.
We now have three widely available options for treating COVID-19. The treatment that’s best for you will depend on infection status, your symptoms, your risk for complications and your overall cancer therapy plan.